Across TCGA pan-cancer cohorts, IFITM9P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated IFITM9P data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher IFITM9P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IFITM9P expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.
UVM, ACC, and KIRC are the cancer types where IFITM9P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.